Trim AMAT 40-50% as bear case dominates near-term; structural floor prevents full exit
Bear case dominates near-term across three decisive evidence points: (1) FCF collapsed ~90% from $2B+ baseline to $210M despite record $9.12B revenue and $2.538B net income quarter; (2) at ~27x forward earnings, AMAT is most expensive in equipment peer set (ASML 22-25x, LRCX 18-20x, KLA ~20x) with asymmetric multiple-compression risk given 30Y at 5% and ~85% probability of no 2026 Fed cuts; (3) confirmed technical breakdown with three failed $548 retests, MACD negative since 7/30, RSI 43.76, price below four key MAs. However, structural franchise quality (40% ROE, $8.24B cash, near-zero net debt, 2.51x current ratio, validated AI capex tailwind) and intact 200 SMA at $393 (26% below current) argue against full capitulation—the 40-50% trim calibrated to -3 to -5% alpha band reflects genuine deterioration without overshooting against franchise fundamentals. Re-entry requires BOTH 50 SMA reclaim AND MACD positive cross AND RSI >50; full exit warranted only on weekly close below $393.
| Position | Action |
|---|---|
| Market execution near $496 | Trim ~one-third of AMAT exposure |
| Retest of $500-510 | Trim ~one-third of AMAT exposure |
| Confirmed weakness toward $465 (Bollinger lower band) or 50 SMA rejection at $555-565 | Trim final ~one-third of AMAT exposure |
| Weekly close below $436 (July swing low) | Reduce to 0.5% portfolio weight |
| Weekly close below $393 (200 SMA) | Full exit/reassessment |
| Post-trim retained core position | Implement collar: sell $580-600 calls to finance $470-480 puts, 30-45 DTE |
| Smaller protective sleeve | Buy far-dated $400-420 puts, 60-90 DTE, sized to AMAT exposure welcome as a long |
| 25-30% of trimmed capital | Rotate into less-extended AI infrastructure names (ASML, diversified semi ETF) |
AMAT's record quarterly print combined with a 33% technical drawdown creates an asymmetric entry: the business is printing best-ever numbers while smart money distributes to weak hands, setting up the next leg up within a secular AI CapEx uptrend.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | $515.88 | bearish |
| 50 SMA | $560.80 | bearish |
| 200 SMA | $393.80 | bullish |
| RSI (14) | 43.76 | bearish |
| MACD | -10.23 | bearish |
| MACD Signal | -8.67 | bearish |
| MACD Histogram | -1.55 | neutral |
| Bollinger Upper Band | $568.88 | neutral |
| Bollinger Mid Band | $516.04 | neutral |
| Bollinger Lower Band | $463.20 | neutral |
| VWMA (20) |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Confirmed close above 50 SMA at ~$555-565 with rising slope
Then: First re-entry confirmation (requires paired with MACD and RSI)
Valuation is not premium—forward P/E of 27x is fair with 58% EPS growth
↩ rebuts: “Bear's 'elevated P/E of 42.7x' argument”
EV: +37% to +45% (from $496 to $680-$720) · concedes: China export controls are a real risk; 50 SMA overhead resistance is real; MACD is currently negative; Burry's short position is valid positioning data; The 33% drawdown did happen
AMAT at $496 is not a gift but a trap; the record earnings selloff, premium valuation versus peers, 86% no-cut macro backdrop, Burry's disclosed short, collapsing FCF (down 90% to $210M), and deteriorating technicals all point to asymmetric risk favoring downside to $420 over 6-9 months.
EV: -$76 (15% downside to $420) · concedes: Timing matters—Burry was wrong on Tesla before the recovery; Cash position of $8.24B and 0.72x Debt/EBITDA are real strengths; If FCF collapse is purely AR timing, it reverses next quarter; AI infrastructure buildout is real and multi-year; Record quarterly earnings are genuine achievements
→ vs conservative: The $210M FCF print shows working-capital movement during accelerating shipments ($1.396B receivables build), not customer distress—no supplied evidence of cancellations, rising delinquencies, or falling demand; cash conversion risk is real but customer distress is not a proven fact
→ vs neutral: 200-day SMA ($393.80) intact should determine core retention, not whether to ignore short-term tape; 'accumulate on weakness' at ~$496 after 85–98% YTD advance is not the same as being prepared for the next 11–15% decline to $440–$420; waiting to reclaim 50-day SMA means paying ~13% more at ~30x forward earnings
| $525.41 |
| bearish |
| ATR (14) | 33.33 | neutral |
| Spot Close | $496.21 | bearish |
Support: 463.2 · 436.33 · 393.8 | Resistance: 568.88 · 560.8 · 525.41 · 515.88
AMAT is in a corrective phase following a parabolic advance from ~$430.66 (2026-05-12) to $739.67 intraday high (2026-06-30), followed by a ~33% drawdown to $436.33 (2026-07-29). The stock now oscillates in a $487–$563 range with three failed attempts to reclaim ~$548 in August. The 50 SMA has begun flattening and rolling over ($560.80), acting as overhead resistance rather than support. MACD has been negative since ~2026-07-30 and continues to deepen, while RSI has failed to reclaim the 50 midline despite not reaching oversold territory. The 200 SMA remains the secular bull case last line of defense; a weekly close below $393.80 would invalidate the long-term thesis. Trading recommendation is to BUY only on confirmed reversal patterns with stops at the Bollinger lower band ($463.20), targeting VWMA at $525.41.
Market Cap
$393.97B
Trailing P/E
42.74x
Forward P/E
27.05x
PEG Ratio
1.0
Price / Book
15.37x
EPS (TTM)
$11.61
Forward EPS
$18.34
Dividend Yield
0.43%
Beta
1.618
52-Week High
$739.67
52-Week Low
$154.47
50-Day Avg
$560.86
200-Day Avg
$392.92
Revenue (TTM)
$30.84B
Gross Profit (TTM)
$15.23B
EBITDA (TTM)
$10.15B
Net Income (TTM)
$9.27B
Gross Margin
49.4%
Operating Margin
33.7%
Net Margin
30.1%
ROE
41.1%
ROA
15.5%
Book Value / Share
$32.28
Apr-26 Revenue
$7,910M
Apr-26 Gross Profit
$3,947M
Apr-26 Gross Margin
49.9%
Apr-26 Operating Income
$2,523M
Apr-26 Operating Margin
31.9%
Apr-26 EBITDA
$3,429M
Apr-26 Net Income
$2,806M
Apr-26 Diluted EPS
$3.51
Apr-26 R&D
$1,027M
Apr-26 SG&A
$397M
Apr-26 Operating Cash Flow
$845M
Apr-26 CapEx
($635M)
Apr-26 Free Cash Flow
$210M
Apr-26 Dividends Paid
($365M)
Apr-26 Buybacks
($400M)
Apr-26 Cash & Equivalents
$6,301M
Apr-26 Short-Term Investments
$1,940M
Apr-26 Total Cash + Investments
$8,241M
Apr-26 Total Debt
$7,268M
Apr-26 Net Debt
$154M
Apr-26 Inventory
$6,343M
Apr-26 Receivables
$6,811M
Apr-26 Total Assets
$40,286M
Apr-26 Total Equity
$23,909M
Apr-26 Current Ratio
2.42x
Apr-26 Working Capital
$13,573M
Apr-26 Change in Receivables
($1,396M)
Apr-26 Change in Inventory
($319M)
Apr-26 End Cash Position
$6,359M
Debt/Equity
25.5x
Total Debt / EBITDA
0.72x
Net Debt / Equity
0.006x
Inventory Turnover
5.1x
Diluted Shares
799M
Impairment Charges (2 quarters)
$1.14B
FCF (TTM)
$3.20B
YoY Revenue Growth (Apr-26)
+11.4%
QoQ Revenue Growth (Apr-26)
+12.8%
Forward EPS Growth
+58%
Strengths
Concerns
Applied Materials operates from fundamental strength with record TTM revenue of $30.84B, best-in-class ~49.4% gross margins, 41.1% ROE, and a net-cash balance sheet. The company sits at the epicenter of AI-driven semiconductor capex expansion through exposure to advanced-node logic, HBM memory build-outs, and advanced packaging (2.5D/3D, hybrid bonding). However, valuation is stretched at 42.74x trailing P/E with aggressive consensus estimates implying 58% EPS growth. Near-term concerns include depressed FCF ($210M in Apr-26) from working-capital buildup, rising inventory and impairment charges, and moderating buybacks as CapEx ramps. Long-term quality is exceptionally high, but the easy money likely has been made in the 2025-2026 run-up; new entries best on pullbacks toward the 200-day MA (~$393) or confirmed FCF recovery.
Macro: The macro backdrop is characterized by a Polymarket signal showing an 86% probability of zero Fed rate cuts in 2026, indicating the Fed is on hold and monetary policy is a headwind rather than a tailwind. Rising 10-year yields and a global bond sell-off are the dominant macro themes creating a risk-off environment with negative bond/equity correlation. Trump \"economic warfare\" rhetoric is cited as pushing yields and oil higher. AI demand remains validated with Anthropic reporting 14x YoY revenue growth, but geopolitical tensions around US-China trade, CHIPS Act revisions, and equipment export restrictions create ongoing tail risks.